Production and persistence of specific antibodies in COVID-19 patients with hematologic malignancies: role of rituximab

Abstract The ability of patients with hematologic malignancies (HM) to develop an effective humoral immune response after COVID-19 is unknown.A prospective study was performed to monitor the immune response to SARS-CoV-2 of patients with follicular lymphoma (FL), diffuse large B-cell lymphoma feline 1-hcpch vaccine (DLBCL), chronic lymphoproliferat

read more


Antibody response among nucleic acid amplification test confirmed COVID-19-positive patients: A cross-sectional study

Introduction: Coronavirus disease 2019 (COVID-19) pandemic has caused immense loss of lives, enormous devastation, and has affected lives globally.Timely diagnosis is necessary to contain its spread.While it is important to test symptomatic individuals and high-risk contacts through reliable and confirmatory test (nucleic acid amplification test [N

read more

Neurofibromatosis Type 1 Vasculopathy Presenting as Branch Retinal Vein Occlusion: Case Report and Review of the Literature

Systemic vascular occlusive disease associated with neurofibromatosis type 1 (NF1) has been reported in the aortic, cerebral, renal, celiac, and mesenteric vessels and is referred to as NF1 vasculopathy.Although retinal vascular involvement in patients with NF1 usually manifests as retinal capillary hemangiomatosis, a few cases nightstick twm-850xl

read more